Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Change in Cash (2022 - 2025)

Historic Change in Cash for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • 60 Degrees Pharmaceuticals' Change in Cash rose 2463.7% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $815091.0, marking a year-over-year decrease of 2467.84%. This contributed to the annual value of -$483132.0 for FY2024, which is 12573.11% down from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Change in Cash of $2.1 million as of Q3 2025, which was up 2463.7% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Change in Cash peaked at $2.2 million during Q3 2023, and registered a low of -$1.6 million during Q4 2024.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Change in Cash averaged around $258794.5, with its median value being -$76055.0 (2023).
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Change in Cash skyrocketed by 80482.96% in 2023, and later crashed by 1196717.93% in 2024.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Change in Cash stood at -$174528.0 in 2022, then soared by 56.42% to -$76055.0 in 2023, then crashed by 2058.09% to -$1.6 million in 2024, then surged by 230.92% to $2.1 million in 2025.
  • Its Change in Cash was $2.1 million in Q3 2025, compared to -$1.5 million in Q2 2025 and $1.8 million in Q1 2025.